2nd Quarter - Report
FEROX STRATEGIES for VIATRIS INC
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to drug shortages. Issues related to FDA generic drug approval process. General issues related to State-Foreign Operations Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.